Prospective Audit to Study urokinaSe use to restore Patency in Occluded centRal venous caTheters in haematology and oncology patients (PASSPORT 2).

Mick John KumwendaLisa DoughertyAndrew JacksonSteve Hill

Published in: The journal of vascular access (2020)

In this study, treatment of dysfunctional central venous catheter using standardised urokinase doses was safe and effective in restoring patency when no other mechanical causes could account for central venous catheter dysfunction.

Keyphrases

end stage renal disease
ejection fraction
palliative care
peritoneal dialysis
ultrasound guided